BRONCHOGENIC CYST

BRONCHOGENIC CYST was reported 27 times

BRONCHOGENIC CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 beta Lactamase Inhibitor [EPC] 1 0.0002
1 Progesterone [EPC] 2 0.0001
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
3 Antimycobacterial [EPC] 2 0.0001
4 Thiazide-like Diuretic [EPC] 3 0.0001
5 Rifamycin Antibacterial [EPC] 2 0.0001
6 Vitamin D3 Analog [EPC] 1 0.0000
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
8 Anti-IgE [EPC] 3 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
10 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
11 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
12 Cardiac Glycoside [EPC] 1 0.0000
13 Catecholamine [EPC] 1 0.0000
14 Estrogen [EPC] 2 0.0000
15 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
16 alpha-Adrenergic Blocker [EPC] 1 0.0000
17 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
18 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
19 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
20 Interferon beta [EPC] 1 0.0000
21 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
22 Benzodiazepine [EPC] 3 0.0000
23 Platelet Aggregation Inhibitor [EPC] 2 0.0000
24 Progestin [EPC] 1 0.0000
25 Proton Pump Inhibitor [EPC] 2 0.0000
26 beta-Adrenergic Blocker [EPC] 1 0.0000
27 Corticosteroid [EPC] 4 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
29 GLP-1 Receptor Agonist [EPC] 1 0.0000
30 Insulin Analog [EPC] 1 0.0000
31 Loop Diuretic [EPC] 1 0.0000